Assessing, communicating and managing cardiovascular disease risk: a practical summary of the 2023 guideline
Australian Prescriber · 23.04.2024 · 47 (2) · 57-63
DOI: 10.18773/austprescr.2024.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Australian Prescriber, online erschienen am 23.04.2024. Verfasst von Garry Jennings und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Heart Foundation of Australia, Melbourne. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The outdated cardiovascular disease risk calculator has been reported to overestimate cardiovascular disease risk for a contemporary Australian population, and does not include relevant variables, such as socioeconomic disadvantage, which has been shown to increase the incidence of both heart attack and stroke. The 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk marks a major milestone as the first update to Australia's cardiovascular disease prevention guideline in over a decade. The new guideline may help to refine and recategorise risk estimates, hence improving the discriminatory and predictive value of the new calculator. The new Australian Cardiovascular Disease Risk Calculator expresses risk scores as a percentage estimate of a person's probability of dying or being hospitalised due to cardiovascular disease within the next 5 years. The new calculator expresses risk scores as low (less than 5%), intermediate (5% to less than 10%), or high (10% or higher) risk over 5 years. Reclassification factors built into the new calculator are designed to help clinicians individualise risk estimates. These factors include ethnicity (e.g. First Nations status), family history of premature cardiovascular disease, severe mental illness, kidney disease and coronary artery calcium score. The new calculator also uses optional diabetes-specific variables (supporting a more granular cardiovascular disease risk assessment of people with type 2 diabetes). People who meet the clinically determined high-risk criteria (chronic kidney disease, familial hypercholesterolaemia) should not progress through the Australian Cardiovascular Disease risk calculator, but move straight to management. For a person with a cardiovascular disease risk score recorded from the outdated calculator, clinicians may want to reassess their risk using the new calculator the next time the person attends.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Heart Foundation of Australia, Melbourne.
- National Heart Foundation of Australia, Sydney.
- University of Tasmania, Hobart.
- Refer to Appendix 1 of 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk Appendices.
ORCID-Profile: Garry Jennings, Natalie Raffoul, Mark Nelson
Zitieren
APA
Jennings, G., Raffoul, N., Nelson, M., & Australian Guideline For Assessing And Managing Cardiovascular Disease Risk, E. S. G. F. T. (2024). Assessing, communicating and managing cardiovascular disease risk: a practical summary of the 2023 guideline. Australian Prescriber, 47(2), 57-63. https://doi.org/10.18773/austprescr.2024.014
Vancouver
Jennings G, Raffoul N, Nelson M, Australian Guideline For Assessing And Managing Cardiovascular Disease Risk ESGFT. Assessing, communicating and managing cardiovascular disease risk: a practical summary of the 2023 guideline. Australian Prescriber. 2024;47(2):57-63. doi:10.18773/austprescr.2024.014
BibTeX
@article{Jennings2024,
author = {Jennings, Garry and Raffoul, Natalie and Nelson, Mark and Australian Guideline For Assessing And Managing Cardiovascular Disease Risk, Expert Steering Group For The},
title = {Assessing, communicating and managing cardiovascular disease risk: a practical summary of the 2023 guideline},
journal = {Australian Prescriber},
year = {2024},
volume = {47},
number = {2},
pages = {57--63},
doi = {10.18773/austprescr.2024.014}
}
EUVIMED